The results in Table 3 showed that all adjusted values for serum AFP, serum IL-13, the presence of G/G genotype in IL-13 rs20541, the presence of T/T genotype in IL-13R2 rs5946040, the presence of T/T genotype in PD-L1 rs2282055, the absence of C/C genotype STAT6 rs167769, and the absence of C allele carrier in YAP1 rs11225163 were all still significantly associated to HCC development in NASH with p < 0.05. The gene discussed is IL13; the disease is hepatocellular carcinoma.